Moreover, in tumor bearing mice after administration of the combination of either DOX or R with SLENU, SOD activities were significantly decreased compared to those of DOX and R administrated alone (mean 10.698 U/gPr and 12.251 U/gPr, P < 0.0001) and were close to those of the healthy controls. This evidence concerns the gene SOD1 and neoplasm.